We are live on
!
Find out more
SWK
Stephen W. Kidder Portfolio holdings
AUM
$396M
Turnover
8.86%
1-Year Est. Return
42.65%
This Fund
S&P 500
This Quarter
Est. Return
+4.02%
1 Year Est. Return
+42.65%
3 Year Est. Return
+94.74%
5 Year Est. Return
+121.43%
10 Year Est. Return
+416.4%
AUM
$264M
AUM Growth
+$4.03M
(+1.5%)
Cap. Flow
-$6.76M
Cap. Flow
% of AUM
-2.56%
Top 10 Holdings %
Top 10 Hldgs %
37.76%
Holding
92
New
1
Increased
13
Reduced
53
Closed
1
Avg Time Held
3
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
2.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$515K |
| 2 |
Analog Devices
ADI
|
+$406K |
| 3 |
J.M. Smucker
SJM
|
+$332K |
| 4 |
Novo Nordisk
NVO
|
+$189K |
| 5 |
Unilever
UL
|
+$140K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.28M |
| 2 |
Cisco
CSCO
|
+$996K |
| 3 |
Enbridge
ENB
|
+$602K |
| 4 |
3M
MMM
|
+$589K |
| 5 |
Oracle
ORCL
|
+$535K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Healthcare | 22.47% |
| 3 | Industrials | 16.1% |
| 4 | Consumer Staples | 9.8% |
| 5 | Miscellaneous | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Factset
FDS
$10.6B
| $286K | 0.11% |
1,725
-50
| -3% | -$8.18K |
2016 Q1
5 quarters
|
|
77
Pfizer
PFE
$168B
| $286K | 0.11% |
8,971
| – | – |
2014 Q3
11 quarters
|
|
78
Fidelity National Information Services
FIS
$18.5B
| $273K | 0.1% |
3,200
| – | – |
2014 Q3
11 quarters
|
|
79
Phillips 66
PSX
$117B
| $273K | 0.1% |
3,309
| – | – |
2015 Q4
6 quarters
|
|
80
ConocoPhillips
COP
$176B
| $264K | 0.1% |
6,005
| – | – |
2015 Q4
6 quarters
|
|
81
Hershey
HSY
$34.1B
| $258K | 0.1% |
2,400
-100
| -4% | -$11K |
2014 Q3
11 quarters
|
|
82
Johnson Controls International
JCI
$88.8B
| $244K | 0.09% |
5,639
-12
| -0.2% | -$502 |
2013 Q2
16 quarters
|
|
83
Kimberly-Clark
KMB
$34.8B
| $235K | 0.09% |
1,825
| – | – |
2014 Q3
11 quarters
|
|
|
84
Novo Nordisk
NVO
$172B
| $202K | 0.08% |
+9,390
| New | +$189K |
2017 Q2
0 quarters
|
|
|
VNR
85
DELISTED
Vanguard Natural Resources, LLC
VNR
| $1K | ﹤0.01% |
15,288
| – | – |
2016 Q4
2 quarters
|
|
86
Target
TGT
$70.3B
| – | – |
-3,855
| Closed | -$213K | – |
|
|
FCSE
87
DELISTED
FOCUS ENHANCEMENTS INC
FCSE
| $0 | ﹤0.01% |
11,500
| – | – |
2013 Q2
16 quarters
|
|
Similar funds
SAM
HP
WLPWM
KC
PCM
RGC
MCMU
NWAG
Stephen W. Kidder's Q2 2017 Portfolio in Review
As of Q2 2017, Stephen W. Kidder held 92 positions worth $264M, up 1.5% from $260M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Trading was light in Q2 2017: portfolio turnover was 2.2%. Stephen W. Kidder opened 1 new position and exited 1, leaving the 92-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
- Stephen W. Kidder's largest Q2 2017 buy was Novo Nordisk: 9,390 shares worth $202K.
- Stephen W. Kidder added most to Fortive in Q2 2017, an estimated $515K increase.
- Stephen W. Kidder's biggest Q2 2017 reduction was ExxonMobil, cutting an estimated $1.28M.
- Stephen W. Kidder fully exited Target in Q2 2017, selling an estimated $213K.
- Stephen W. Kidder's ten largest holdings make up 38% of its $264M portfolio in Q2 2017.
- Stephen W. Kidder opened 1 new position and closed 1 in Q2 2017.
- Stephen W. Kidder's portfolio value rose 1.5% quarter-over-quarter to $264M.
Based on Stephen W. Kidder's 13F filing for Q2 2017, filed 26 Jul 2017.